News
New bacterial mRNA vaccine technology shows promise in fighting plague, and could help address the global threat of ...
3h
AllAfrica on MSNMore Than 14 Million Children Unvaccinated in 2024 - ReportThe WHO and UNICEF have warned that widespread misinformation and severe international aid cuts are widening coverage gaps, putting millions of children at risk.More than 14 million children remained ...
Losing the status is a far bigger deal than most people likely know, and getting it back is no fast or easy feat.
11h
Calgary Herald on MSNWith more than 1,300 cases, Alberta passes U.S. in confirmed measles count as new advisories issuedAlberta’s confirmed measles case count has officially surpassed the United States. After accruing 30 new cases over the ...
An estimated 14.3 million children globally remain unvaccinated and vulnerable to vaccine-preventable illnesses – meaning ...
"Our results, based on 1.2 million Danish children and a study period covering 24 years, provide robust evidence supporting ...
The federal government has dismissed charges against a Utah plastic surgeon accused of throwing away COVID-19 vaccines worth thousands of dollars during the pandemic.
A study of more than 1 million people found no link between aluminum in vaccines and an increased risk of autoimmune disease, allergies and autism.
15h
What to Expect on MSN7 Things to Know About Infant Vaccines Before Baby ArrivesAt baby's 2-month well visit, he'll receive a number of other essential immunizations, including RV (rotavirus), DTaP (diphtheria, tetanus and pertussis, which is also known as whooping cough), Hib ...
16h
The Mirror US on MSNMeasles signs and what to do as cases reach record high sparking new warningMeasles cases in the US have reached a new high, hitting the biggest numbers since the US eliminated the disease 25 years ago ...
20h
Zacks Investment Research on MSNFDA Accepts GSK Filing for Expanded Use of RSV Shot in Younger AdultsGSK plc GSK announced that the FDA has accepted its regulatory filing seeking to expand the use of its RSV vaccine, Arexvy, in adults under 50 who are at a higher risk of the disease. A final decision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results